Caplin Point Laboratories Ltd (NSE:CAPLIPOINT)

Q3 2026 Caplin Point Laboratories Ltd Earnings Call Transcript

Feb 5, 2026 / 10:30 AM GMT

Release Date Price: ₹1903.9 (-0.29%)

Transcript

Key Points

Positve

Caplin Point Laboratories Ltd (BOM:524742) reported a 10.6% year-on-year revenue growth, indicating a positive financial performance.
The company has achieved faster approval timelines for its products, averaging 14 to 15 months compared to the industry average of 20 months.
Caplin Point Laboratories Ltd (BOM:524742) has successfully completed EUGMP and Saudi FDA audits with no critical observations, showcasing strong compliance.
The company is expanding its product portfolio with 10 products pending FDA review and plans to have 65 ADF approved products soon.
Caplin Point Laboratories Ltd (BOM:524742) is implementing innovative visual SOPs to enhance compliance and productivity in pharma manufacturing.

Negative

The oncology API facility has faced delays, pushing expected completion to Q3 2027, which may impact growth timelines.
Sales growth has slowed to 10-11% for the first nine months, below the company's historical average of 15%.
The company is in a consolidation phase, with expectations of low double-digit growth for the next 18 to 24 months.
There are challenges in the ecosystem in Tamil Nadu, affecting project timelines and efficiency.
Despite new plant commercialization, operating costs have remained stable, raising questions about cost management and efficiency.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CAPL.NS - Caplin Point Laboratories Ltd
Q3 2026 Caplin Point Laboratories Ltd Earnings Call
Feb 05, 2026 / 10:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, you are connected for Kaplan Point Laboratories Limited conference call. Please stay connected. The conference will begin shortly.

Thank you.

Ladies and gentlemen, good day and welcome to Kaplan Point Laboratories Limited Q3F26 earnings conference call hosted by Dollli Capital Markets Private Limited. As a reminder, all participants' line will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing, then 0 on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Ms.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.